Hekun Liu

926 total citations
33 papers, 626 citations indexed

About

Hekun Liu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hekun Liu has authored 33 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Immunology. Recurrent topics in Hekun Liu's work include Signaling Pathways in Disease (12 papers), Peptidase Inhibition and Analysis (6 papers) and Lipid metabolism and disorders (4 papers). Hekun Liu is often cited by papers focused on Signaling Pathways in Disease (12 papers), Peptidase Inhibition and Analysis (6 papers) and Lipid metabolism and disorders (4 papers). Hekun Liu collaborates with scholars based in China, United States and Taiwan. Hekun Liu's co-authors include Kun Ping Lu, Xiao Zhen Zhou, Min Zheng, Jichuang Wang, Long Wang, Dayun Yang, Wenxian Lu, Xin‐Hua Liao, Sizhong Zhang and Önder Albayram and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Hekun Liu

32 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hekun Liu China 15 358 166 101 100 99 33 626
Jin-Ho Kang South Korea 14 258 0.7× 113 0.7× 112 1.1× 60 0.6× 91 0.9× 26 629
Yiqing Mao China 12 240 0.7× 108 0.7× 68 0.7× 107 1.1× 88 0.9× 29 558
Minseob Eom South Korea 14 352 1.0× 172 1.0× 65 0.6× 121 1.2× 69 0.7× 45 797
Lin Shen China 17 289 0.8× 108 0.7× 95 0.9× 130 1.3× 54 0.5× 66 717
Shu Zhuo China 15 326 0.9× 85 0.5× 138 1.4× 123 1.2× 62 0.6× 22 674
Aninda Basu United States 14 381 1.1× 173 1.0× 71 0.7× 80 0.8× 93 0.9× 19 650
Beatriz Morancho Spain 13 224 0.6× 192 1.2× 142 1.4× 75 0.8× 82 0.8× 19 648
Yujie Ma China 15 326 0.9× 143 0.9× 45 0.4× 44 0.4× 73 0.7× 30 648

Countries citing papers authored by Hekun Liu

Since Specialization
Citations

This map shows the geographic impact of Hekun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hekun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hekun Liu more than expected).

Fields of papers citing papers by Hekun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hekun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hekun Liu. The network helps show where Hekun Liu may publish in the future.

Co-authorship network of co-authors of Hekun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hekun Liu. A scholar is included among the top collaborators of Hekun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hekun Liu. Hekun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ni, Xuejun, et al.. (2024). Integrative bioinformatics and experimental validation of hub genetic markers in acne vulgaris: Toward personalized diagnostic and therapeutic strategies. Journal of Cosmetic Dermatology. 23(5). 1777–1799. 3 indexed citations
2.
Jin, Yiyi, et al.. (2024). Pin1 Exacerbates Non-Alcoholic Fatty Liver Disease by Enhancing Its Activity through Binding to ACC1. International Journal of Molecular Sciences. 25(11). 5822–5822. 3 indexed citations
3.
Chen, Yuwen, et al.. (2024). Pin1 Downregulation Is Involved in Excess Retinoic Acid-Induced Failure of Neural Tube Closure. International Journal of Molecular Sciences. 25(11). 5588–5588.
4.
Huang, Yun-Peng, et al.. (2023). A prediction model for moderate to severe cancer-related fatigue in colorectal cancer after chemotherapy: a prospective case‒control study. Supportive Care in Cancer. 31(7). 426–426. 6 indexed citations
5.
Chen, Yuwen, et al.. (2023). Disorders of the central nervous system: Insights from Notch and Nrf2 signaling. Biomedicine & Pharmacotherapy. 166. 115383–115383. 6 indexed citations
6.
Chen, Yuwen, Xiaojun Hou, Fan Yang, et al.. (2022). The role of peptidyl-prolyl isomerase Pin1 in neuronal signaling in epilepsy. Frontiers in Molecular Neuroscience. 15. 1006419–1006419. 4 indexed citations
7.
Zhang, Tao, Dongmei Chen, Long Wang, et al.. (2021). Inhibition of Death-associated Protein Kinase 1 protects against Epileptic Seizures in mice. International Journal of Biological Sciences. 17(9). 2356–2366. 14 indexed citations
8.
Wang, Xiaohan, Binghui Zhang, Jie Lin, et al.. (2021). Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma. Cancer Letters. 524. 161–171. 31 indexed citations
9.
Hou, Xiaojun, Fan Yang, Yuanxiang Lin, et al.. (2021). The Pin1-CaMKII-AMPA Receptor Axis Regulates Epileptic Susceptibility. Cerebral Cortex. 31(6). 3082–3095. 10 indexed citations
10.
Wang, Jichuang, Nan Zhang, Wenxian Lu, et al.. (2018). Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway. Cancer Letters. 444. 82–93. 47 indexed citations
11.
Zheng, Min, Dayun Yang, Wenxian Lu, et al.. (2017). Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways. Scientific Reports. 7(1). 43639–43639. 37 indexed citations
12.
Yang, Dayun, Jichuang Wang, Min Zheng, et al.. (2017). A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways. Journal of Controlled Release. 269. 405–422. 55 indexed citations
13.
Zhu, Zhendong, Xin‐Hua Liao, Min Zheng, et al.. (2017). MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Scientific Reports. 7(1). 45915–45915. 47 indexed citations
14.
Zheng, Min, Yaoji Liang, Suqin Wu, et al.. (2015). Recognition of Cytosolic DNA Attenuates Glucose Metabolism and Induces AMPK Mediated Energy Stress Response. International Journal of Biological Sciences. 11(5). 587–594. 8 indexed citations
15.
Dong, Feng, Qingquan Chen, Feng‐Qing Wang, et al.. (2014). Multiple gene mutations in patients with type 2 autoimmune pancreatitis and its clinical features. Central European Journal of Immunology. 39(1). 77–82. 10 indexed citations
16.
Xu, Liangpu, et al.. (2010). A New β-Thalassemia Deletion Mutation [Codon 36 (–C)] Observed in a Chinese Woman. Hemoglobin. 34(6). 599–603. 6 indexed citations
17.
Wang, Xizhen, Sizhong Zhang, Yuanzhong Chen, et al.. (2009). APM1 gene variants −11377C/G and 4545G/C are associated respectively with obesity and with non-obesity in Chinese type 2 diabetes. Diabetes Research and Clinical Practice. 84(3). 205–210. 27 indexed citations
18.
Zhang, Sizhong, Hekun Liu, Xizhen Wang, et al.. (2009). Association of −394C>G and −420C>G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese. Molecular and Cellular Biochemistry. 330(1-2). 31–38. 16 indexed citations
19.
Liu, Hekun, Suyun Chen, Sizhong Zhang, et al.. (2007). Adiponectin Gene Variation −4522C/T Is Associated with Type 2 Diabetic Obesity and Insulin Resistance in Chinese. Journal of genetics and genomics. 34(10). 877–884. 10 indexed citations
20.
Liu, Hekun, Sizhong Zhang, Jianyin Lin, et al.. (2005). Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism. 54(5). 568–572. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin-Ho Kang Breakdown of academic impact, for papers by Yiqing Mao Breakdown of academic impact, for papers by Minseob Eom Breakdown of academic impact, for papers by Lin Shen Breakdown of academic impact, for papers by Shu Zhuo Breakdown of academic impact, for papers by Aninda Basu Breakdown of academic impact, for papers by Beatriz Morancho Breakdown of academic impact, for papers by Yujie Ma
Rankless by CCL
2026